Email UpdatesThe PCSS-MOUD Exchange is a four-session course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. PCSSMOUD-X is intended for an interprofessional audience. Prescribers with frontline experience prescribing MOUD and developing clinic workflows will be available during all four sessions to answer participants’ questions and discuss real-world cases. These sessions will take place on:
- February 1 (this session)
- February 8
- February 15
- February 22
Session 1 Description:
Have you considered treating patients with opioid use disorder (OUD) using Medications for Opioid Use Disorder (MOUD)? Have you wondered what is required to prescribe buprenorphine or other pharmacotherapies? If you answered yes to either or both of these questions, this PCSS-MOUD Exchange session could provide you with the critical information and steps in determining the readiness of your site and clinical leadership. Initiating Medications for Opioid Use Disorder (MOUD) into your setting requires that you understand how pharmacotherapies work, including buprenorphine and its various formulations.
Educational Objectives:
- Identify the three FDA-approved medications to treat OUD and describe the specific formulations of buprenorphine
- Understand how each medication works, what side-effects may exist, and how prescribers/patients make decisions about which to choose
- Review the risks of opioid overdose and role of Naloxone
- Identify next steps (i.e., financial and clinical) to guide implementation of MOUD
- Identify resources targeted to both prescribing (e.g., MD, DO, NP, PA, etc.) and non-prescribing (e.g., counselors, social workers, clinic administrators, etc.) healthcare team members